Kfir Molakandov
CIK: 0002120197
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NCEL
NewcelX Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Molakandov Kfir
Molakandov Kfir (SEC CIK 0002120197) files insider reports with the SEC as VP of R&D of NewcelX Ltd. (NCEL).
Signal8 holds 1 ownership filing by Molakandov Kfir, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Molakandov Kfir's filings is in ZURICH.
Other insiders filing for NewcelX Ltd. (NCEL)
- Samuel Olivier, Director
- Revel Michel, CSO and Director
- Galili Tamar, Director
- Twito Ronen, Chairman and CEO
- Hagai Omri, Chief Financial Officer
- Oren Liora, Director